Search Results
12 items found for "herbal compounds"
- S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
Immunology S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia Published date July 1, 2024 Abstract "Imatinib Network pharmacology analysis identified six herbal compounds-ampelopsin, ellagic acid, colchicine, epigallocatechin Morang, Manisha Bisht, Vikas Upadhyay, Surabhi Thapliyal, Shailendra Handu Tags RNA-seq , S1PR , SphK1 , herbal compounds , imatinib resistance , leukemia Source Contribute to the GPCR News Coming soon Become a Contributor
- Elucidation of active components and target mechanism in Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia
A dynamic mass redistribution technique was applied to evaluate compounds on four GPCRs. Molecular docking was conducted on GPR35-active compounds and GPR35 crystal structure. Results: Seventy compounds were isolated and twelve showed GPCR activity. Seventeen compounds showed NO inhibitory activity. Several compounds showed multi-target properties.
- Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking
In this study, we explored the capacity of bioactive compounds derived from Gnetum gnemon (GG) for the We retrieved targets for GG-derived compounds and GPCRs-related cancer from databases. We identified a total of 265 targets associated with GG-derived bioactive compounds for the treatment CCND1, and PPARG, which demonstrate as treatment targets for GPCRs-related cancer using GG-derived compounds This study presents a novel approach for comprehending the therapeutic mechanisms of GG-derived active compounds
- Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design
Subsequently, we selected a compound from a library of backbone cyclic peptides generated toward the PAR PH binding motif, namely the lead compound, Pc(4-4). While the detection of PAR2 may serve as a predictor for ovarian cancer, the novel Pc(4-4) compound may
- Emerging GPCR targets for AUD: Insights from preclinical studies
Specifically, we focus on preclinical evidence of compounds with attractive pharmacological profiles
- Ep 78 with Dr. Stuart Maudsley
technology-based start-up company, HeptOME , to help screen and develop novel longevity/disease-regulating compounds
- The pyruvate-GPR31 axis promotes transepithelial dendrite formation in human intestinal dendritic cells
fundamental function of cDC1 by allowing efficient uptake of gut luminal antigens, such as dietary compounds
- Ep 152 with Dr Arthur Christopoulos
They discussed strategies for analyzing large compound screening data, emphasizing robust assays and They also discussed the potential of certain drugs, like flumazenil, as 'nails' or compounds that could
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
different species, we plan to adapt this technology for high-throughput screening of pharmacological compound The platform revealed different mechanisms-of-action of our lead compound when benchmarked against other
- Ep 150 with Dr GPCR Team
research fellow at Monash University, John plays a pivotal role in the pharmacological screening of compounds
- Terms and Conditions | Dr. GPCR Ecosystem
All rights, title, and interest in and to the Services and its components will remain with and belong in any manner that interferes with or disrupts the integrity or performance of the Services or its components
- Content and Conduct Policy | Dr. GPCR Ecosystem
Content, computer code, products, software, aggregate user review ratings, and all other elements and components